Neurociencias
Fachbereich
Xavier
Montalbán Gairín
Publikationen, an denen er mitarbeitet Xavier Montalbán Gairín (39)
2023
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55–IL6ST Gene Region in Immature Dendritic Cells
Frontiers in Immunology, Vol. 12
2021
-
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry
PLoS ONE, Vol. 16, Núm. 10 October
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I)
Revista de neurologia, Vol. 72, Núm. 11, pp. 397-406
-
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II)
Revista de neurologia, Vol. 72, Núm. 12, pp. 433-442
2019
-
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856
2018
2016
-
Analysis of plasminogen genetic variants in multiple sclerosis patients
G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079
-
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3
-
Novel insights into the multiple sclerosis risk gene ANKRD55
Journal of Immunology, Vol. 196, Núm. 11, pp. 4553-4565
-
Revisión de las novedades del XXXI Congreso ECTRIMS 2015, presentadas en la VIII Reunión Post-ECTRIMS
Revista de Neurologia, Vol. 62, Núm. 12, pp. 559-569
2015
-
A functional variant that affects exon-skipping and protein expression of SP140 as genetic mechanism predisposing to multiple sclerosis
Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5619-5627
-
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
Clinica Chimica Acta, Vol. 438, pp. 67-69
-
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 12, pp. 1498-1512
-
Consenso español actualizado sobre el uso del natalizumab (Tysabri®)-2013
Neurologia, Vol. 30, Núm. 5, pp. 302-314
-
Genome-wide significant association with seven novel multiple sclerosis risk loci
Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855
-
Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154
-
Review of the novelties from the 2014 ECTRIMS-ACTRIMS joint congress, presented at the 7th post-ECTRIMS meeting (II)
Revista de Neurologia, Vol. 61, Núm. 6, pp. 271-283